$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical drugs
Medical drugs
Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Dosage and usage of aficamten-MYQORZO
2026-02-01 22:25:32
Check Details
How effective is the Lao version of capmatinib generic drug?
2026-02-01 22:25:32
Check Details
Larotrectinib/Vitax shows "prolonged survival benefit" in NTRK fusion treatment of advanced lung cancer
2026-02-01 22:25:32
Check Details
Detailed description of the clinically recommended usage and dosage of Selinisol/Silvio Tablets
2026-02-01 22:25:32
Check Details
How much does a box of Vigabatrin/vigabatrin cost in each specification in 2026?
2026-02-01 22:25:32
Check Details
Will taking Mobotinib/Mobotinib cause hair loss? Sharing real experiences of side effects
2026-02-01 22:25:32
Check Details
FDA approves aficamten-MYQORZO for the treatment of obstructive hypertrophic cardiomyopathy
2026-02-01 22:25:32
Check Details
Scope of application of ivonib (Tosuvo) in solid tumors or other cancers
2026-02-01 22:25:32
Check Details
Is the price of Mitotane drug affordable for the average family in the long term?
2026-02-01 22:25:32
Check Details
How can patients with the high price of pemigatinib obtain the drug reasonably?
2026-02-01 22:25:32
Check Details
The latest price trend of Erdafitinib in 2026 and the key factors affecting drug prices
2026-02-01 22:25:32
Check Details
Market reference price and drug price change trend of Erlotinib in 2026
2026-02-01 22:25:32
Check Details
1
2
...
2430
2431
2432
2433
2434
2435
2436
...
2439
2440
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Neurokinin Receptor Antagonists: A Non-Hormonal Approach to Menopausal Hot Flashes and Sleep Disturbances
2
FDA Approves Tauklarify for Tau PET Imaging in Alzheimer's Disease Assessment
3
First CELMoD Drug Zenbexus Wins FDA Accelerated Approval for Multiple Myeloma
4
FDA Approves First mRNA Flu Vaccine mFLUSIVA
5
FDA Approves Orzeyful, the World's First Orexin Receptor Agonist for Narcolepsy Type 1, Ushering in a New Era of Root-Cause Therapy
6
FDA Approves Lytenava: First Ophthalmic Bevacizumab for Wet AMD
7
AbbVie’s TEPKINLY (epcoritamab) Plus R² Granted EU Approval for Relapsed/Refractory Follicular Lymphoma
8
Global Oncology Update: Breakthroughs in Advanced Cancer Survival and Novel Therapies
9
Phase 1 Study Progress of Ceralasertib in Combination with Durvalumab for Advanced NSCLC and HNSCC
10
Global Breakthroughs in Cancer Drugs and Advanced Treatment Technologies
11
ROS and Cancer: The Potential of Natural Antioxidants
12
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment